Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Callisia N. Clarke MD
Assistant Professor
Department of Surgery
Division of Surgical Oncology

OFFICE ADDRESS:
The Hub for Collaborative Medicine
8701 Watertown Plank Road
Milwaukee, WI 53226

EDUCATION:
09/1998 - 05/2002 B.A., The College of Wooster, Wooster, OH
08/2002 - 06/2006 M.D., University of Cincinnati College of Medicine, Cincinnati, OH

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
07/2006 - 06/2012 Resident, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267
07/2012 - 06/2013 Chief Resident, Department of Surgery, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 54267
07/2013 - 06/2016 Fellow, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030

MILITARY SERVICE:
None

FACULTY APPOINTMENTS:
07/2006 - 06/2013 Clinical Instructor of Surgery, Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267
07/2009 - 06/2010 House Physician, Medical Staff, Surgery, Shriners Hospital for Children, Cincinnati, OH 45267
07/2013 - 07/2016 Clinical Specialist, Surgical Oncology, The University Of Texas MD Anderson Cancer, Houston, TX 77030
09/2016 - Present Assistant Professor, Surgery, Division of Surgical Oncology, Milwaukee, WI 53226

ADMINISTRATIVE APPOINTMENTS:
07/2012 - 06/2013 Graduate Medical Education Residency Advisory Representative, Surgery, The University of Cincinnati College of Medicine, Cincinnati, OH 45267
07/2015 - 06/2016 Administrative Fellow for Medical Quality Improvement, Surgical Oncology, Houston Texas 2015- 2016The University of Texas MD Anderson Cancer Center, Houston, TX 77030

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
None

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
None

RESEARCH ADMINISTRATIVE APPOINTMENTS:
None

HOSPITAL STAFF PRIVILEGES:
09/2016 - Present Froedtert Memorial Lutheran Hospital, 9200 West Wisconsin Avenue, Milwaukee, WI 53226
01/2017 - Present Children's Hospital of Wisconsin, 8915 W. Connell Ct, Milwaukee, WI53226

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
General Surgery ABS
11/2013
11/2023
Complex General Surgical Oncology ABS
01/2017
01/2027
 
Certificates
Issued By Issue DateExpiration
Fundamentals of Laparoscopic Surgery
SAGES
03/2012
None
Advanced Trauma Life Support
ACS
06/2013
None
Advanced Cardiac Life Support
AHA
03/2015
03/2017
Certified in Medical Quality
ABMQ
05/2015
None
 

Licensure
Number Issue DateExpiration
Ohio Medical License
35.092759
12/12/2008
04/01/2017
Texas Medical License
P5611
02/28/2013
02/28/2019
Wisconsin Medical License
66205-20
09/16/2017
10/31/2017
 

AWARDS AND HONORS:
08/2002 - Present Gaston Scholarship - Academic excellence, University of Cincinnati College of Medicine
02/2006 - Present Alpha Omega Alpha
05/2006 - Present Ruth Lyons Award - Academic excellence & Leadership University of Cincinnati College of
03/2007 - Present City of Cincinnati Leaders of the Future Award - Young Professionals Under 30
05/2007 - Present Speaking of Women's Health Symposium Honoree - Community Health Education
10/2009 - Present Winner, Basic Science Presentation, Annual Meeting Ohio Chapter - ACS
02/2010 - Present First Place, Basic Science Award. Cincinnati Surgical Society Resident Research Competition
06/2012 - Present James M. Hurst Trauma Resident of the Year Award
03/2015 - Present Fellow Award for the Best Basic Science Research Paper, 68th SSO Annual Cancer Symposium
Medicine

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
02/2006 - Present Alpha Omega Alpha Medical Honor Society
07/2010 - Present American College of Surgeons
07/2013 - Present Society of Surgical Oncology
07/2013 - Present American Society of Clinical Oncology
11/2016 - Present Wisconsin Surgical Society
12/2016 - Present Milwaukee Academic Surgical Society
12/2016 - Present Milwaukee Gastrointestinal Society
01/2017 - Present Central Surgical Society
02/2017 - Present Association for Academic Surgery
02/2017 - Present Society of Black Academic Surgeons
03/2017 - Present North American Neuroendocrine Tumor Society

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Editorship
02/2017 - Present Ad Hoc Reviewer, Journal of Surgical Oncology
03/2017 - 08/2017 Invited Editor Focused Issue,Journal Gastroenterology Oncology

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
None

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
03/2017 - 03/2020 Member, Membership Committee, Society of Surgical Oncology

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Non-Peer Review
Title:
Parathyroid Cancer Research Grant
Source:
MD Anderson Cancer Center
Role:
Co-Investigator
Dates:
07/01/2012 - Present
Direct Funds:
$80,000
 
Prior
Peer Review
Title:
T32 Training Grant - 1T32GM08478
Source:
NIH
Role:
Fellow, Department of Surgery University of Cincinnati
Dates:
07/01/2008 - 06/30/210
 
Title:
T32 Training Grant - 5T32CA009599-24
Source:
NIH
Role:
Fellow, Department of Surgical Oncology, MD Anderson Cancer Center
Dates:
07/01/2014 - 06/30/2015
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
Local
1/27/2017 - Surgical Management of Locally Advanced Pancreas Cancer Case Presentation. Medical College of Wisconsin Pancreas Symposium. Milwaukee, WI.
 
Regional
11/11/2016 - Pancreatic Neuroendocrine Case Presentations. North American Neuroendocrine Tumor Society Regional Conference. Milwaukee, WI.
 
National
8/1/2017 - Updates in Melanoma Management. 115th National Medical Association Annual National Convention and Scientific Assembly. Philadelphia, PA.
 
International
None
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
Local
Clarke CN, Kuboki S, Edwards MJ,Lentsch AB., Is CXC Chemokine Receptor-1 signaling after Liver Ischemia/Reperfusion in Mice Hepatoprotective?, Cincinnati Surgical Society Resident Research Competition, CincinnatiOhio., 02/01/2010
 
Regional
Clarke CN, Kuboki S, Edwards MJ,Lentsch AB., Is CXC Chemokine Receptor-1 signaling after Liver Ischemia/Reperfusion in Mice Hepatoprotective?, Annual Meeting Ohio Chapter-ACS, Cleveland,Ohio., 05/01/2009
 
National
Clarke CN, Tsuei BJ,Butler KL., Equine Related Injury: A retrospective analysis of outcomes over a 10 year period., Society of Black Academic Surgeons, 17th Annual Scientific Session, Chicago, Illinois., 04/12/2007
Clarke CN, Everly JJ, Tevar AD., Predictors of Poor Outcomes in Patients with Nonalcoholic Steatohepatitis Undergoing Orthotopic Liver Transplantation., Society of Black Academic Surgeons, 19th Annual Scientific Session, Seattle,Washington, 04/02/2009
Clarke CN, Kuboki S, Tevar AD, Edwards MJ, Lentsch AB., Roles of NF-κB and STAT-3 in CXC chemokine-mediated hepatocyte proliferation and cell death., The American College of Surgeons, 94th Annual Clinical Congress, Chicago, Illinois., 10/12/2009
Clarke CN, Kuboki S, Sakai N, Tevar AD, Blanchard J,Edwards MJ, Lentsch AB., Potential Hepatoprotective Role for CXC Chemokine Receptor-1 after Liver Ischemia/Reperfusion in Mice., Experimental Biology, Anaheim, California., 04/24/2010
Clarke CN, Sakai N, Tevar AD,Blanchard J,Edwards MJ,Lentsch AB., CXC chemokine signaling in hepatocytes: NF-κB and STAT-3 signaling mediates hepatocyte proliferation and cell death., Experimental Biology, Anaheim, California, 04/25/2010
Clarke CN, Sakai N, Tevar AD, Blanchard J, Edwards MJ,Lentsch AB., CXC Chemokines are Not Direct Mitogens for Hepatocytes., Experimental Biology, Anaheim, California., 04/25/2010
Clarke CN, Sakai N, Tevar AD, Blanchard J,Edwards MJ,Lentsch AB., CXC chemokine signaling in hepatocytes and the roles of NF-κB and STAT-3 in mediating hepatocyte proliferation and cell death., Society of Black Academic Surgeons, 20th Annual Scientific Session, Durham, North Carolina., 04/30/2010
Clarke CN, Lee MS, Wei W, Manyam G, Jiang Z, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang G, Simon, I, Bernards, R, Overman M, Mills G, Maru D, Kopetz S., Proteomic features of colorectal cancer independently predict relapse-free survival and identify tumor subgroups independent of oncogenic mutations. Plenary Podium Presentation, 68th SSO Annual Cancer Symposium- Plenary Podium Presentation, Houston, Texas, 03/26/2015
Clarke CN, Patel S, Day R, George S, Sweeney C, Avaloa Monetes De Oca G, Ait Aiss M, Grubbs EG, Bednarski BK, Lee JE, Skibber JM, Aloia TA., Implementation of a standardized electronic tool improves compliance accuracy and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures., 11th Annual Academic Surgical Congress, Jacksonville, FL, 02/03/2016
Christakis I, Busaidy N, Clarke CN, Kwatampora, Warneke CL, Silva A, Williams M, Grubbs EG, Lee JE, Perrier, N, Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer, 69th SSO Annual Cancer Symposium, Boston MA, March 2016., 03/03/2016
Clarke CN, Rodriguez-Bigas MA, Chang GJ, Bednarski B, Feig B, You YN., Neutrophil-lymphocyte Ratio Confers Prognostic Significance in MSI-high Colorectal Cancer, 69th SSO Annual Cancer Symposium, Boston, MA, 03/04/2016
 
International
None
 

COMMITTEE SERVICE:
Medical College of Wisconsin
06/2005 - 06/2007 Member Grievance and Promotions Committee, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267
07/2009 - 06/2011 Resident Duty Hours Committee, The University of Cincinnati Office of Graduate
07/2009 - 06/2011 Member Admissions Committee, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267
11/2016 - Present Member, Institutional Review Board (IRB) Committee, Medical College of Wisconsin 9200 W. Wisconsin Ave, Milwaukee WI 53226
01/2017 - Present Member, Resident Clinical Competency Committee, The Medical College of Wisconsin, 9200 West Wisconsin Ave, Milwaukee
Medical Education, 231 Albert Sabin Way, Cincinnati, OH 45267
 
Hospital
10 - Present 10
None
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Community/Lay Public
None
 
Medical Student Education
09/2001 - Present M3 Surgical Clerkship Lecture- Pancreas
 
Resident and Fellow Education
09/2016 - Present Weekly Surgical Oncology Resident Teaching Conference
03/06/2017 - Present PGY2 Curriculum Lecture - Management of Colorectal Liver Metastasis
 
Continuing Medical Education
02/21/2016 - Present St. Agnes Cancer Center Fond du Lac - Sentinel Lymph Node Biopsy for Melanoma: How, Why and Who?
 
Graduate Student Education
None
 
Postdoctoral Fellow Education
None
 

EXTRAMURAL TEACHING:
Continuing Medical Education
None
 
Graduate Student Education
None
 

EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED:
High School Students
None
 
Undergraduate Students
None
 
Medical Students
Zoe Morgan MCW, 12/2016 - Present Medical Student Summer Research Mentor
 
Postdoctoral Students
None
 
Clinical/Research Fellows
None
 
Residents
None
None
 
Faculty
None
None
 

PROGRAMMATIC DEVELOPMENTS:
 
Research Programs
None
 
Clinical Programs
None
 
Community Programs
None
 

COMMUNITY SERVICE ACTIVITIES:
None
 

GLOBAL HEALTH ACTIVITIES:
Village Life Outreach Project - Board Member 2010-2013, Physician volunteer
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Jourden MJ, Clarke CN, Palmer AK, Barth EJ, Prada RC, Hale RN, Fraga D, Snider MJ, Edmiston PL. Changing the substrate specificity of creatine kinase from creatine to glycocyamine: evidence for a highly evolved active site. Biochem Biophys Acta. 2007; 1774(12):1519-27.
2. Clarke CN, Tsuei BJ, Butler KL. Equine Related Injury: A retrospective analysis of outcomes over a 10 year period. Am J Surg 2008; 195:702-4.
3. Kuboki S, Saki N, Eismann T, Huber N, Clarke CN, Schuster R, Blanchard J, Edwards MJ, Lentsch AB. The peptidyl-prolyl isomerase, Pin1, facilitates NF-κB binding in hepatocytes and protects against hepatocellular injury after ischemia/reperfusion in mice. J Hepatol. 2009; 51(2):296-306.
4. Clarke CN, Kuboki S, Tevar A, Lentsch AB, Edwards MJ. CXC Chemokines Play A Critical Role in Liver Injury, Recovery and Regeneration. Am J Surg 2009; 198(3):415-9.
5. Tevar AD, Clarke CN, Wang J, Rudich SM, Woodle ES, Lentsch AB, Edwards MJ. Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. J Am Coll Surg 2010; 210(4):515-26.
6. Sakai N, Clarke CN, Tevar AD, Edwards MJ, Lentsch AB. Portal Vein Ligation Accelerates Tumor Growth in Ligated, but not Contralateral Lobes. World J Gastroenterol 2010; 16(30):3816-26.
7. Clarke CN, Sakai N, Tevar AD, Schuster R, Edwards MJ, Lentsch AB. STAT3 Does Not Regulate Acute Liver Injury After Ischemia/Reperfusion. J Surg Res 2011; 171(2):814-8.
8. Goodman MD, Makley AT, Huber NL, Clarke CN, Friend LA, Schuster RM, Bailey SR, Barnes SL, Dorlac WC, Johannigman JA, Lentsch AB, Pritts TA. Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury. J Surg Res 2011; 165 (1):30-7.
9. Tevar AD, Clarke CN, Schuster R, Wang J, Edwards MJ, Lentsch AB. The Effect of Hepatic Ischemia Reperfusion Injury in a Murine Model of Nonalcoholic Steatohepatitis. J Surg Res.2011; 169(1):7-14.
10. Clarke CN, Kuboki S, Sakai N, Tevar AD, Blanchard J, Edwards MJ, Lentsch AB. Potential Hepatoprotective Role for CXC Chemokine Receptor-1 after Liver Ischemia/Reperfusion in Mice. Hepatology 2011; 53 (1):261-71.
11. Clarke CN, Kopetz S. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. J Gastrointest Oncol 2015;6(6):660-667.
12. Clarke CN, Kwatampora L, Silva A, Zorba, Y, Williams MD, Kopetz ES, Lee JE, Perrie, ND, Busaidy NL. Recurrent parathyroid carcinoma and the need for molecular profiling to aid in prognostication and therapeutics. J Clin Oncol (Meeting Abstracts) May 2015 vol. 33 no. 15_suppl e17012.
13. Christakis I, Busaidy N, Clarke CN, Kwatampora, Warneke CL, Silva A, Williams M, Grubbs EG, Lee JE, Perrier N. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol 2016; 23: 2889-97.
14. Christakis IA, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND. Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in MEN1 Patients; A Clinico-Pathologic Challenge. The MD Anderson Case Series and Review of the Literature. Int J Surg. 2016; (31) 10-16.
15. Christakis IA, Silva Figueroa AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Wanted: Oncologic Progress for the Treatment of Parathyroid Carcinoma. Accepted - In Press. Journal of Surgical Oncology.
16. Clarke CN, Patel S, Day R, George S, Sweeney C, Avaloa Monetes De Oca G, Ait Aiss M, Grubbs EG, Bednarski BK, Lee JE, Skibber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. Accepted - In Press. Surgery
17. Yamashita S, Brudvik KW, Kopetz SE, Dipen M, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA and Vauthey JN Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. Accepted - In Press Annals of Surgery.
18. Silva Figueroa AM, Clarke CN, Christakis IA, , Kwatampora LJ, Warneke CL,Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. A Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. Accepted - In Press JACS
19. Clarke CN , Lee MS, Wei W , Manyam G, Jiang Z, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang G, Simon, I, Bernards, R, Overman M, Mills G, Maru D, Kopetz S. Proteomic features of colorectal cancer independently predict relapse-free survival. Submitted - Annals of Surgical Oncology.
20. Jourden MJ, Clarke CN, Palmer AK, Barth EJ, Prada RC, Hale RN, Fraga D, Snider MJ, Edmiston PL. Changing the substrate specificity of creatine kinase from creatine to glycocyamine: evidence for a highly evolved active site. Biochim Biophys Acta. 2007 Dec;1774(12):1519-27.
21. Kuboki S, Sakai N, Clarke C, Schuster R, Blanchard J, Edwards MJ, Lentsch AB. The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury. J Hepatol. 2009 Aug;51(2):296-306. PMCID: PMC2747648
22. Clarke CN, Tsuei BJ, Butler KL. Equine-related injury: a retrospective analysis of outcomes over a 10-year period. Am J Surg. 2008 May;195(5):702-4.
23. Clarke CN, Kuboki S, Tevar A, Lentsch AB, Edwards M. CXC chemokines play a critical role in liver injury, recovery, and regeneration. Am J Surg. 2009 Sep;198(3):415-9. PMCID: PMC2736150
24. Tevar AD, Clarke C, Wang J, Rudich SM, Woodle ES, Lentsch AB, Edwards ML. Clinical review of nonalcoholic steatohepatitis in liver surgery and transplantation. J Am Coll Surg. 2010 Apr;210(4):515-26. PMCID: PMC4607044
25. Clarke C, Sakai N, Tevar AD, Schuster R, Edwards MJ, Lentsch AB. STAT3 does not regulate acute liver injury after ischemia/reperfusion. J Surg Res. 2011 Dec;171(2):814-8. PMCID: PMC2965827
26. Sakai N, Clarke CN, Schuster R, Blanchard J, Tevar AD, Edwards MJ, Lentsch AB. Portal vein ligation accelerates tumor growth in ligated, but not contralateral lobes. World J Gastroenterol. 2010 Aug 14;16(30):3816-26. PMCID: PMC2921094
27. Goodman MD, Makley AT, Huber NL, Clarke CN, Friend LA, Schuster RM, Bailey SR, Barnes SL, Dorlac WC, Johannigman JA, Lentsch AB, Pritts TA. Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury. J Surg Res. 2011 Jan;165(1):30-7. PMCID: PMC4607063
28. Clarke C, Kuboki S, Sakai N, Kasten KR, Tevar AD, Schuster R, Blanchard J, Caldwell CC, Edwards MJ, Lentsch AB. CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury. Hepatology. 2011 Jan;53(1):261-71. PMCID: PMC3058860
29. Tevar AD, Clarke CN, Schuster R, Wang J, Edwards MJ, Lentsch AB. The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis. J Surg Res. 2011 Jul;169(1):e7-14. PMCID: PMC4599341
30. Clarke CN, Sussman JJ, Abbott DE, Ahmad SA. Factors affecting readmission after pancreaticoduodenectomy. Adv Surg. 2013;47:99-110.
31. Clarke CN, Kopetz ES. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies. J Gastrointest Oncol. 2015 Dec;6(6):660-7. PMCID: PMC4671844
32. Christakis I, Bussaidy N, Clarke C, Kwatampora LJ, Warneke CL, Silva AM, Williams MD, Grubbs EG, Lee JE, Perrier ND. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol. 2016 09;23(9):2889-97.
33. Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016 Jul;31:10-6.
34. Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Oncologic progress for the treatment of parathyroid carcinoma is needed. J Surg Oncol. 2016 Nov;114(6):708-713.
35. Clarke CN, Patel SH, Day RW, George S, Sweeney C, Monetes De Oca GA, Aiss MA, Grubbs EG, Bednarski BK, Lee JE, Bodurka DC, Skibber JM, Aloia TA. Implementation of a standardized electronic tool improves compliance, accuracy, and efficiency of trainee-to-trainee patient care handoffs after complex general surgical oncology procedures. Surgery. 2017 03;161(3):869-875.
36. Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN. Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases. Ann Surg. 2018 03;267(3):514-520. PMCID: PMC5901745
37. Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KPS, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S. Arginine methylation of EGFR: A new biomarker for predicting resistance to anti-EGFR treatment American Journal of Cancer Research. 2017;7(12):2587-2599.
38. Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. J Am Coll Surg. 2017 Mar 15.
39. Berger NG, Tanious MN, Hammad AY, Miura JT, Mogal H, Clarke CN, Christians KK, Tsai S, Gamblin TC. External radiation or ablation for solitary hepatocellular carcinoma: A survival analysis of the SEER database. J Surg Oncol. 2017 Sep;116(3):307-312.
40. Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford). 2017 08;19(8):706-712.
41. Silva JP, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, White S, Rilling W, Gamblin TC. Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis. HPB (Oxford). 2017 08;19(8):659-666.
42. Silva JP, Gorman RA, Berger NG, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. The prognostic utility of baseline alpha-fetoprotein for hepatocellular carcinoma patients. J Surg Oncol. 2017 Dec;116(7):831-840.
43. Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? J Gastrointest Surg. 2017 Nov;21(11):1793-1803.
44. Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S. Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival. Ann Surg Oncol. 2017 Dec;24(13):4051-4058. PMCID: PMC6063735
45. Berger NG, Silva JP, Mogal H, Clarke CN, Bedi M, Charlson J, Christians KK, Tsai S, Gamblin TC. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base. Surgery. 2018 02;163(2):318-323.
46. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T. Minimally invasive hepatectomy conversions: an analysis of risk factors and outcomes. HPB (Oxford). 2018 02;20(2):132-139.
47. Clarke CN, You YN, Feig BW. Cancer of the colon, rectum, and anus The MD Anderson Surgical Oncology Handbook, Sixth Edition. 1 January 2018:304-356.
48. Korphaisarn K, Chou CK, Xia WY, Clarke CN, Katkhuda R, Davis JS, Raghav KP, Liao HW, Wu JY, Menter DG, Maru DM, Hung MC, Kopetz S. Arginine methylation of EGFR: a new biomarker for predicting resistance to anti-EGFR treatment. Am J Cancer Res. 2017;7(12):2587-2599. PMCID: PMC5752698
49. Silva JP, Berger NG, Yin Z, Liu Y, Tsai S, Christians KK, Clarke CN, Mogal H, Gamblin TC. The effect of prior upper abdominal surgery on outcomes after liver transplantation for hepatocellular carcinoma: An analysis of the database of the organ procurement transplant network. Surgery. 2018 05;163(5):1028-1034.
50. Liu C, Berger NG, Rein L, Tarima S, Clarke C, Mogal H, Christians KK, Tsai S, Gamblin TC. Gallbladder carcinoma: An analysis of the national cancer data base to examine hispanic influence. J Surg Oncol. 2018 Jun;117(8):1664-1671.
51. Silva-Figueroa A, Villalobos P, Williams MD, Bassett RL Jr, Clarke CN, Lee JE, Busaidy NL, Perrier ND. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery. 2018 11;164(5):960-964.
52. Silva JP, Klooster B, Tsai S, Christians KK, Clarke CN, Mogal H, Clark Gamblin T. Elective Regional Therapy Treatment for Hepatic Adenoma. Ann Surg Oncol. 2019 Jan;26(1):125-130.
53. Yao JC, Clarke CN, Evans DB. Pancreatic neuroendocrine tumors DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 16 November 2018:1353-1367.
54. Chavez MI, Tsai S, Clarke CN, Aldakkak M, Griffin MO, Khan AH, Ritch PS, Erickson BA, Evans DB, Christians KK. Distal splenorenal and mesocaval shunting at the time of pancreatectomy. Surgery. 2019 02;165(2):298-306.
55. Wilkinson KH, Ethun CG, Hembrook M, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Weber S, Gamblin TC, Cardona K, Clarke CN. Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. J Surg Res. 2019 01;233:154-162.
56. Silva JP, Maurina MN, Tsai S, Christians KK, Clarke CN, Mogal H, Saeian K, Gamblin TC. Effect of Donor Race-Matching on Overall Survival for African-American Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma. J Am Coll Surg. 2019 03;228(3):245-254.
57. Clarke CN, Katsonis P, Hsu TK, Koire AM, Silva-Figueroa A, Christakis I, Williams MD, Kutahyalioglu M, Kwatampora L, Xi Y, Lee JE, Koptez ES, Busaidy NL, Perrier ND, Lichtarge O. Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. J Endocr Soc. 2019 Mar 01;3(3):544-559. PMCID: PMC6372985
58. Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN. RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. J Surg Res. 2019 08;240:130-135.
59. Kotha NV, Baumgartner JM, Veerapong J, Cloyd JM, Ahmed A, Grotz TE, Leiting JL, Fournier K, Lee AJ, Dineen SP, Dessureault S, Clarke C, Mogal H, Zaidi MY, Russell MC, Patel SH, Sussman JJ, Dhar V, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Greer JB, Fackche N, Lowy AM, Kelly KJ. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study. Ann Surg Oncol. 2019 Jul;26(7):2234-2240.
60. Clarke CN, Evans DB. Editorial: Small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors: Observation becoming standard of care? Surgery. 2019 08;166(2):164-165.
61. Gamboa AC, Zaidi MY, Lee RM, Speegle S, Switchenko JM, Lipscomb J, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers BD, Lowy AM, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Lambert L, Hendrix RJ, Abbott DE, Vande Walle K, Lafaro K, Lee B, Johnston FM, Greer J, Russell MC, Staley CA, Maithel SK. Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Jan;27(1):134-146. PMCID: PMC6925634
62. Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK. Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. Surgery. 2019 09;166(3):277-285.
63. Schwartz PB, Vande Walle K, Winslow ER, Ethun CG, Tran TB, Poultsides G, Tseng J, Roggin K, Grignol V, Howard JH, Krasnick BA, Fields RC, Mogal H, Clarke CN, Senehi R, Votanopoulos K, Cardona K, Abbott DE. Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC). Sarcoma. 2019;2019:5395131. PMCID: PMC6589263
64. Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma Journal of Cancer Research and Clinical Oncology. 1 August 2019;145(8):1977-1986.
65. Levinsky NC, Morris MC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Kimbrough C, Fournier K, Lee A, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Zaidi MY, Staley CA, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Ronnekleiv-Kelly S, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Patel SH. Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative. J Gastrointest Surg. 2020 01;24(1):155-164.
66. Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI. Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. J Surg Oncol. 2019 Dec;120(7):1227-1234. PMCID: PMC6857791
67. Stein A, Strong E, Clark Gamblin T, Clarke C, Tsai S, Thomas J, George B, Mogal H. Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review. Ann Surg Oncol. 2020 Jan;27(1):85-97.
68. Zaidi MY, Lee RM, Gamboa AC, Speegle S, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Kelly KJ, Kotha NV, Clarke C, Gamblin TC, Patel SH, Lee TC, Hendrix RJ, Lambert L, Ronnekleiv-Kelly S, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Fackche N, Russell MC, Maithel SK, Staley CA 3rd. Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. Ann Surg Oncol. 2020 Jan;27(1):156-164. PMCID: PMC7195626
69. Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S. Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. Ann Surg Oncol. 2019 Dec;26(13):4515-4521.
70. Wiseman JT, Kimbrough C, Beal EW, Zaidi MY, Staley CA, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Raoof M, Lee B, Fackche N, Greer J, Pawlik TM, Abdel-Misih S, Cloyd JM. Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? Ann Surg Oncol. 2020 Mar;27(3):783-792.
71. Coon C, Berger N, Eastwood D, Tsai S, Christians K, Mogal H, Clarke C, Gamblin TC. Primary Liver Cancer: An NCDB Analysis of Overall Survival and Margins After Hepatectomy. Ann Surg Oncol. 2020 Apr;27(4):1156-1163.
72. Silva-Figueroa AM, Bassett R Jr, Christakis I, Moreno P, Clarke CN, Busaidy NL, Grubbs EG, Lee JE, Perrier ND, Williams MD. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol. 2019 Dec;30(4):285-296.
73. Lee TC, Wima K, Sussman JJ, Ahmad SA, Cloyd JM, Ahmed A, Fournier K, Lee AJ, Dineen S, Powers B, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Zaidi MY, Maithel SK, Leiting J, Grotz T, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Blakely AM, Lee B, Johnston FM, Greer J, Patel SH. Readmissions After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a US HIPEC Collaborative Study. J Gastrointest Surg. 2020 01;24(1):165-176.
74. Hoppenot C, Schuitevoerder D, Izquierdo FJ, Plana A, Pothuri B, Yamada SD, Kim J, Lee NK, Abbott DE, Abdel-Misih S, Ahrendt SA, Al-kasspooles M, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Bowne WB, Brown CK, Catenacci DV, Chan CHF, Chapel DB, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Deneve JL, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Grotz TE, Gushchin V, Hanna N, Harmath C, Hayes-Jordan A, Husain AN, Idrees K, Ihemelandu C, Johnston FM, Jiang D, Kane JM, Karakousis G, Kelly KJ, Kennedy TJ, Keutgen XM, Kindler HL, Kluger MD, Lastra RR, Lee B, Mack LA, Maduekwe UN, Mak GZ, Mammen JMV, Mathew MS, Melis M, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Moroney J, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Royal R, Salti G, Sardi A, Senthil M, Setia N, Sherman SK, Sideris L, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms Annals of Surgical Oncology. 2020.
75. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer HPB. 2020.
76. Plana A, Izquierdo FJ, Schuitevoerder D, Lambert LA, Micic D, Deneve JL, Ahrendt SA, Al-kasspooles M, Amersi F, Bowne WB, Brown CK, Hayes-Jordan A, Kane JM, Kelly KJ, Kennedy TJ, Maduekwe UN, Mak GZ, Melis M, Royal R, Abbott DE, Abdel-Misih S, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Catenacci DV, Chan CHF, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Husain AN, Idrees K, Ihemelandu C, In H, Johnston FM, Jiang D, Karakousis G, Keutgen XM, Kindler HL, Kluger MD, Lee B, Lee NK, Liao CY, Mack LA, Malec M, Mammen JMV, Mathew MS, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Nash GM, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Salti G, Sardi A, Semrad C, Senthil M, Setia N, Sherman SK, Sideris L, Skitzki J, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Lowy AM, Alexander HR, Esquivel J, Foster JM, Labow DM, Levine EA, Staley C, Sugarbaker PH. The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations Annals of Surgical Oncology. 2020.
77. Izquierdo FJ, Plana A, Schuitevoerder D, Hayes-Jordan A, Deneve JL, Al-kasspooles M, Bowne WB, Brown CK, Kane JM, Kelly KJ, Kennedy TJ, Maduekwe UN, Mak GZ, Melis M, Royal R, Abbott DE, Abdel-Misih S, Amersi F, Arrington AK, Badgwell B, Barone RM, Baumgartner JM, Berri RN, Bijelic L, Blazer DG, Catenacci DV, Chan CHF, Cho CS, Choudry MHA, Clarke CN, Cusack JC, Dachman AH, Dineen SP, Eng OS, Fernandez LJ, Fleshman J, Gamblin TC, Gangi A, Georgakis GV, Gilbert EW, Goodman MD, Govindarajan A, Grotz TE, Gushchin V, Hanna N, Harmath C, Husain AN, Idrees K, Ihemelandu C, Jiang D, Johnston FM, Lowy AM, Karakousis G, Keutgen XM, Kindler HL, Kluger MD, Lee B, Mack LA, Mammen JMV, Mathew MS, Melnitchouk N, Merkow RP, Mogal H, Möller MG, Oto A, Pameijer CR, Pappas SG, Polanco PM, Polite BN, Reddy SS, Salti G, Sardi A, Senthil M, Setia N, Sideris L, Sherman SK, Skitzki J, Tun S, Veerapong J, Votanopoulos KI, White MG, Winer JH, Xiao SY, Yantiss RK, Ahuja N, Alexander HR, Esquivel J, Foster JM, Labow DM, Lambert LA, Levine EA, Staley C, Sugarbaker PH, Bartlett DL, Turaga K. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors Annals of Surgical Oncology. 2020.
78. Powers BD, Felder S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Staley CA, Maithel SK, Patel S, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Johnston FM, Greer J, Cloyd JM, Kimbrough C, Grotz T, Leiting J, Fournier K, Lee AJ, Imanirad I, Dessureault S, Dineen SP. Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study Annals of Surgical Oncology. 2020.
79. Lee RM, Zaidi MY, Gamboa AC, Speegle S, Kimbrough CW, Cloyd JM, Leiting JL, Grotz TE, Lee AJ, Fournier KF, Powers BD, Dineen SP, Baumgartner J, Veerapong J, Clarke CN, Sussman JJ, Patel S, Hendrix RJ, Lambert LA, Vande Walle KA, Abbott DE, LaRocca CJ, Raoof M, Fackche N, Johnston FM, Staley CA, Maithel SK, Russell MC. What is the Optimal Preoperative Imaging Modality for Assessing Peritoneal Cancer Index? An Analysis From the United States HIPEC Collaborative. Clin Colorectal Cancer. 2020 03;19(1):e1-e7.
80. Geurts JL, Strong EA, Wang TS, Evans DB, Clarke CN. Screening guidelines and recommendations for patients at high risk of developing endocrine cancers. J Surg Oncol. 2020 May;121(6):975-983.
81. Thalji SZ, Tsai S, Gamblin TC, Clarke C, Christians K, Charlson J, Ethun CG, Poultsides G, Grignol VP, Roggin KK, Votanopoulos K, Fields RC, Abbott DE, Cardona K, Mogal H, other members of the US Sarcoma Collaborative. Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. J Surg Oncol. 2020 Jun;121(7):1140-1147.
82. Schwartz PB, Poultsides G, Roggin K, Howard JH, Fields RC, Clarke CN, Votanopoulos K, Cardona K, Winslow ER. PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. J Surg Res. 2020 07;251:228-238. PMCID: PMC7765565
83. Shelby RD, Suarez-Kelly LP, Yu PY, Hughes TM, Ethun CG, Tran TB, Poultsides G, King DM, Bedi M, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Howard JH, Cardona K, Grignol V. Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020 Jun;121(8):1249-1258.
84. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Standards. Ann Surg Oncol. 2020 Jun;27(6):1743-1752.
85. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. Ann Surg Oncol. 2020 Jun;27(6):1753-1760.
86. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors. Ann Surg Oncol. 2020 Jun;27(6):1788-1792.
87. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma. Ann Surg Oncol. 2020 Jun;27(6):1774-1779.
88. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases. Ann Surg Oncol. 2020 Jun;27(6):1768-1773.
89. Chicago Consensus Working Group. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases. Ann Surg Oncol. 2020 Jun;27(6):1761-1767.
90. Liu C, Rein L, Clarke C, Mogal H, Tsai S, Christians KK, Gamblin TC. Comparison of overall survival in gallbladder carcinoma at academic versus community cancer centers: An analysis of the National Cancer Data Base. J Surg Oncol. 2020 Aug;122(2):176-182.
91. Turgeon MK, Gamboa AC, Lee RM, Zaidi MY, Kimbrough C, Grotz T, Fournier K, Powers B, Dineen S, Veerapong J, Clarke C, Mogal H, Patel SH, Lambert L, Ronnekleiv-Kelly S, Raoof M, Fackche N, Greer JB, Staley CA, Cloyd JM, Maithel SK, Winer JH. The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC. Ann Surg Oncol. 2020 Dec;27(13):4894-4907. PMCID: PMC7644621
92. Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S. Value of Pretreatment <sup>18</sup>F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. Front Oncol. 2020;10:500. PMCID: PMC7180175
93. Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S. Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. HPB (Oxford). 2020 Dec;22(12):1745-1752.
94. Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S. Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. Front Oncol. 2020;10:460. PMCID: PMC7175033
95. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of desmoplastic small round cell tumor, breast, and gastrointestinal stromal tumors. Cancer. 2020 06 01;126(11):2566-2570.
96. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Palliative care considerations. Cancer. 2020 06 01;126(11):2571-2576.
97. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of gastric metastases. Cancer. 2020 06 01;126(11):2541-2546.
98. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of neuroendocrine tumors. Cancer. 2020 06 01;126(11):2561-2565.
99. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases. Cancer. 2020 06 01;126(11):2534-2540.
100. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of ovarian neoplasms. Cancer. 2020 06 01;126(11):2553-2560.
101. Clarke CN, Kopetz ES. Molecular Markers and Mutational Analysis Rectal Cancer: Modern Approaches to Treatment. 1 January 2018:295-312.
102. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma. Cancer. 2020 06 01;126(11):2547-2552.
103. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Standards. Cancer. 2020 06 01;126(11):2516-2524.
104. Fackche N, Schmocker RK, Kubi B, Cloyd JM, Ahmed A, Grotz T, Leiting J, Fournier K, Lee AJ, Powers B, Dineen S, Veerapong J, Baumgartner JM, Clarke C, Gamblin TC, Patel SH, Dhar V, Hendrix RJ, Lambert L, Abbott DE, Pokrzywa C, Lafaro K, Lee B, Zaidi MY, Maithel SK, Johnston FM, Greer JB. The Utility of Preoperative Tumor Markers in Peritoneal Carcinomatosis from Primary Appendiceal Adenocarcinoma: an Analysis from the US HIPEC Collaborative. J Gastrointest Surg. 2021 Feb 25.
105. Leiting JL, Day CN, Harmsen WS, Cloyd JM, Abdel-Misih S, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapongh J, Baumgartner JM, Clarke C, Mogal H, Russell MC, Zaidi MY, Patel SH, Morris MC, Hendrix RJ, Lambert LA, Abbott DE, Pokrzywa C, Raoof M, Eng O, Johnston FM, Greer J, Grotz TE. The impact of HIPEC <i>vs.</i> EPIC for the treatment of mucinous appendiceal carcinoma: a study from the US HIPEC collaborative. Int J Hyperthermia. 2020;37(1):1182-1188.
106. Kubi B, Gunn J, Fackche N, Cloyd JM, Abdel-Misih S, Grotz T, Leiting J, Fournier K, Lee AJ, Dineen S, Dessureault S, Veerapong J, Baumgartner JM, Clarke C, Mogal H, Patel SH, Dhar V, Lambert L, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Lee B, Maithel SK, Staley CA, Johnston FM, Wang NY, Greer JB. Predictors of Nonhome Discharge after Cytoreductive Surgery and HIPEC Journal of Surgical Research. November 2020;255:475-485.
107. Clarke CN, Alexander HR, Quebbeman EJ, Gamblin TC. The history of isolated hepatic perfusion for liver metastases and current indications for use Cancer Regional Therapy: HAI, HIPEC, HILP, ILI, PIPAC and Beyond. 1 January 2019:247-256.
108. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer. 2020 06 01;126(11):2525-2533.
109. Schwartz PB, Stahl CC, Ethun C, Marka N, Poultsides GA, Roggin KK, Fields RC, Howard JH, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE. Retroperitoneal sarcoma perioperative risk stratification: A United States Sarcoma Collaborative evaluation of the ACS-NSQIP risk calculator. J Surg Oncol. 2020 Jun 17. PMCID: PMC7744355
110. Eng OS, Blakely AM, Lafaro KJ, Fournier KF, Fackche NT, Johnston FM, Dineen S, Powers B, Hendrix R, Lambert LA, Ronnekleiv-Kelly S, Walle KV, Grotz TE, Leiting JL, Patel SH, Dhar VK, Baumgartner JM, Lowy AM, Clarke CN, Mogal H, Zaidi MY, Staley CA, Kimbrough C, Cloyd JM, Lee B, Raoof M. Institutional variation in recovery after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: An opportunity for enhanced recovery pathways. J Surg Oncol. 2020 Oct;122(5):980-985.
111. Barnes CA, Aldakkak M, Christians KK, Clarke CN, Dua K, George B, Ritch PS, Kamgar M, Hall WA, Kulkarni N, Erickson BA, Evans DB, Tsai S. Radiographic patterns of first disease recurrence after neoadjuvant therapy and surgery for patients with resectable and borderline resectable pancreatic cancer. Surgery. 2020 09;168(3):440-447.
112. Taskin OC, Clarke CN, Erkan M, Tsai S, Evans DB, Adsay V. Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication. J Gastrointest Oncol. 2020 Jun;11(3):548-558. PMCID: PMC7340800
113. Clarke CN, Evans DB. Treatment sequencing for pancreatic neuroendocrine tumors: daring to challenge the status quo. J Gastrointest Oncol. 2020 Jun;11(3):545-547. PMCID: PMC7340804
114. Wiseman JT, Ethun CG, Cloyd JM, Shelby R, Suarez-Kelly L, Tran T, Poultsides G, Mogal H, Clarke C, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick B, Fields R, Walle KV, Ronnekleiv-Kelly S, Howard JH, Cardona K, Grignol V. Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. J Surg Oncol. 2020 Nov;122(6):1189-1198.
115. Gamboa AC, Lee RM, Turgeon MK, Zaidi MY, Kimbrough CW, Grotz TE, Leiting J, Fournier K, Lee AJ, Dineen SP, Powers BD, Veerapong J, Baumgartner JM, Clarke CN, Mogal H, Patel SH, Lee TC, Lambert LA, Hendrix RJ, Abbott DE, Pokrzywa C, Raoof M, Eng OS, Johnston FM, Greer J, Cloyd JM, Maithel SK, Staley CA. Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Dec;27(13):4980-4995. PMCID: PMC7988818
116. Strong EA, Park SH, Ethun CG, Chow B, King D, Bedi M, Charlson J, Mogal H, Tsai S, Christians K, Tran TB, Poultsides G, Grignol V, Howard JH, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Cullinan D, Fields RC, Gamblin TC, Cardona K, Clarke CN. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery. 2020 10;168(4):760-767.
117. Kim RY, Christians KK, Aldakkak M, Clarke CN, George B, Kamgar M, Khan AH, Kulkarni N, Hall WA, Erickson BA, Evans DB, Tsai S. Total Neoadjuvant Therapy for Operable Pancreatic Cancer. Ann Surg Oncol. 2021 Apr;28(4):2246-2256.
118. Stahl CC, Schwartz PB, Ethun CG, Marka N, Krasnick BA, Tran TB, Poultsides GA, Roggin KK, Fields RC, Clarke CN, Votanopoulos KI, Cardona K, Abbott DE. Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database. Ann Surg Oncol. 2021 Mar;28(3):1690-1696. PMCID: PMC7897241
119. Chavez MI, Gholami S, Kim BJ, Margonis GA, Ethun CG, Tsai S, Christians KK, Clarke C, Mogal H, Maithel SK, Pawlik TM, D’Angelica MI, Aloia TA, Eastwood D, Gamblin TC. Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis Annals of Surgical Oncology. 2021.
 
Books, Chapters, and Reviews
1. Clarke CN. Gastrointesinal Intubation. In: The Mont Reid Surgical Handbook, 6th edition. Stehr W, editor. Philadelphia, PA: Saunders Elsevier Publishing, 2008. p849-855.
2. Clarke CN, A. Tevar, M.J. Edwards, A.B. Lentsch. Liver ischemia/reperfusion injury. In: Molecular Pathology of Liver Diseases. Monga SPS, editor. New York, NY: Springer, 2011. p397-410.
3. Clarke CN, Edwards MJ. Axillary Staging. In:.Advanced Therapy of Breast Disease, 3rd edition. Babiera G, editor. Ontario, Canada: B.C. Decker Publishing, 2012. p527-544.
4. Clarke CN, Sussman JJ, Abbott DE, Ahmad SA. Factors Influencing Readmission Following Pancreaticoduodenectomy. Adv Surg. 2013; 47:99-110.
5. Clarke CN, Badgwell B. Open distal gastrectomy for cancer In: Surgery for Cancers of the Gastrointestinal Tract: A Step-by-Step Approach. Kim J, Aguilar JG, editors. New York, NY: Springer, 2014. p65-74
6. Clarke CN, Kopetz SE. Molecular Markers and Mutational Analysis in: Rectal Cancer: Modern Approaches to Treatment. Chang GJ, editor. In press.
7. Clarke CN, Feig BW, You YN. Cancer of the Colon, Rectum and Anus in: The MD Anderson Surgical Oncology Handbook, 6th edition. Feig, BW editor. Philadelphia, PA: Lippincott Williams and Wilkins. In press.
 
Abstracts
1. Clarke CN. Extensive Aortic Dissection Associated with Cocaine Abuse. Society of General Internal Medicine, Chicago, Illinois 2005
2. Clarke CN, Keegan SP, Mueller EW, Ernst NE, Butler KL. Heparin-induced Thrombocytopenia: Who Gets HIT? Society of Black Academic Surgeons, Cleveland, OH April 2008
3. Clarke CN. Identifiers of Mortality in the Second-Tier Trauma Team Activation: A Ten Year Review. The American Association for the Surgery of Trauma, Maui, Hawaii, September 2008
4. Clarke CN, Tevar AD Edwards MJ, Lentsch AB. Blockade of STAT3 does not alter acute injury after hepatic ischemia/reperfusion in mice. FASEAB, New Orleans, Louisiana, April 2009
5. Clarke CN, Kuboki S, Edwards MJ, Lentsch AB. Potential Hepatoprotective Role for CXC Chemokine Receptor-1 after Liver Ischemia/Reperfusion in Mice. Shock Society- 32nd Annual Meeting on Shock. San Antonio, Texas, June 2009.
6. Huber NL, Sonnier DS, Goodman MD, Makley AT, Bailey SR, Schuster R, Clarke CN, Friend LA, Dorlac WD, Johannigman JA, Lentsch AB, Pritts TA. Hypobaric exposure immediately after burn injury intensifies systemic and intestinal inflammation. Advanced Technology Applications for Combat Casualty Care Conference 2009, St. Pete Beach, Florida, August 2009.
7. Goodman MD, Campion EM, Makley AT, Huber NL, Clarke CN, Friend LA, Schuster RM, Bailey SR, Dorlac WC, Johannigman JA, Lentsch AB, Pritts TA. The inflammatory response after blunt traumatic brain injury is aggravated by hypobaric hypoxia in mice. Advanced Technology Applications for Combat Casualty Care Conference 2009, St. Pete Beach, Florida, August 2009.
8. Clarke CN, Quillan RC, Wang J, Woodle ES, Rudich SM, Lentsch AB, Tevar AD. Laparoscopic Cholecystectomy in the Cirrhotic Patient. The 60th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts. November 2009.
9. Clarke CN, Agarwall AK, You YN, Bednarski B, Rodriguez-Bigas MB, Skibber J, Chang GJ. Robotic Extended Resections for Locally Advanced Anorectal Cancers. Society of Surgical Oncology Annual Meeting, Phoenix, AZ, March 2014
10. Clarke CN, Agarwall AK, Chang GJ. Robotic Cylindrical APR: A technically feasible and oncologically sound approach to surgical resection of anorectal cancers. American Society of Colon and Rectal Surgeons Annual Meeting, Hollywood, FL, May 2014
11. Clarke CN , Lee MS, Wei W , Manyam G, Jiang Z, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang G, Simon, I, Bernards, R, Overman M, Mills G, Maru D, Kopetz S. Proteomic features of colorectal cancer independently predict relapse-free survival. ASCO GI, San Fransisco, CA, January 2015
12. Clarke CN, Korphaisarn K, Jiang Z, Crosby S, Davis DW, Wu w, Raghav KP, Overman MJ, Morris VK, Kee BK, Eng C, Fogelman DR, Navin N, Kopetz ES Antibody-independent isolation and characterization of circulating tumor cells using dielectrophoresis: Fluid flow fractionation in metastatic colorectal cancer. J Clin Oncol 34, 2016 (suppl; abstr e23023)
13. Silva A, Kwatampora L, Christakis I, Warneke CL, Clarke CN, Williams M Grubbs EG, Lee JE, Perrier N, Busaidy N. Prognostic Factors of Overall Recurrence and Survival in Parathyroid Carcinoma; Largest Single Institution Experience. ENDO, Boston, Massachusetts, April 2016